With research facilities in the United States (New Jersey) and China (Shanghai, Suzhou, Nanjing, and Nantong), 1,000+ scientists, and over fifteen years of experience in Investigational New Drug (IND) application, our DMPK team at WuXi AppTec are serving 1,600+ global clients, and have successfully supported 1,500+ IND applications
This suggests that the agency is using 704(a)(4) requests as a strategic tool for international facilities, likely for the purpose of utilizing resources efficiently
Our team of experts is dedicated to providing personalized, safe, and effective programs that incorporate GLP-1 in a way that suits your individual needs
We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater for the active small molecule matrix before encapsulation